234 related articles for article (PubMed ID: 2890093)
21. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
22. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
Riondino S; Gazzaniga PP; Pulcinelli FM
Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
[TBL] [Abstract][Full Text] [Related]
23. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response.
Craven PA; Studer RK; DeRubertis FR
J Clin Invest; 1994 Jan; 93(1):311-20. PubMed ID: 7506712
[TBL] [Abstract][Full Text] [Related]
24. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950
[TBL] [Abstract][Full Text] [Related]
25. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
26. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A
Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145
[TBL] [Abstract][Full Text] [Related]
28. Influence of heat on platelet biochemistry, structure, and function.
Rao GH; Smith CM; Escolar G; White JG
J Lab Clin Med; 1993 Oct; 122(4):455-64. PubMed ID: 8228561
[TBL] [Abstract][Full Text] [Related]
29. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
30. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
[TBL] [Abstract][Full Text] [Related]
31. Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclase.
Roger S; Paysant J; Badier-Commander C; Cordi A; Verbeuren TJ; Félétou M
Vascul Pharmacol; 2010; 53(5-6):281-7. PubMed ID: 20933607
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of platelet aggregation by monoclonal antibody reactive with beta 2-microglobulin chain of HLA complex.
Curry RA; Messner RP; Johnson GJ
Science; 1984 May; 224(4648):509-11. PubMed ID: 6324346
[TBL] [Abstract][Full Text] [Related]
33. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization.
Hatmi M; Rotilio D; Haye B; Antonicelli F; Joseph D; Vargaftig BB
Eur J Pharmacol; 1986 Dec; 132(2-3):219-28. PubMed ID: 3028837
[TBL] [Abstract][Full Text] [Related]
34. Arachidonate is an antagonist of platelet activation by the endoperoxide analog U46619.
Huang EM; Detwiler TC
Biochim Biophys Acta; 1982 Apr; 715(2):246-9. PubMed ID: 6803846
[No Abstract] [Full Text] [Related]
35. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.
Furlong B; Henderson AH; Lewis MJ; Smith JA
Br J Pharmacol; 1987 Apr; 90(4):687-92. PubMed ID: 3495310
[TBL] [Abstract][Full Text] [Related]
36. Monocyclic peroxides as inhibitors of arachidonic acid and prostaglandin endoperoxide analog initiated aggregation of human platelets.
Menzel DB; Roycroft JH; Nixon JR; Isaac SR; Porter NA
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):767-85. PubMed ID: 1005919
[TBL] [Abstract][Full Text] [Related]
37. Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization.
Hatmi M; Lussiana JP; Junien JL; Burke J; Vargaftig BB
Biochem Pharmacol; 1988 Feb; 37(3):481-9. PubMed ID: 2827688
[TBL] [Abstract][Full Text] [Related]
38. Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3).
Soni H; Jain M; Mehta AA
Thromb Res; 2011 Jun; 127(6):551-9. PubMed ID: 21376373
[TBL] [Abstract][Full Text] [Related]
39. Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets.
Sane DC; Bielawska A; Greenberg CS; Hannun YA
Biochem Biophys Res Commun; 1989 Dec; 165(2):708-14. PubMed ID: 2557018
[TBL] [Abstract][Full Text] [Related]
40. Response of human platelets exposed to arachidonate upon stimulation with other agonists: possible role of Ca2+i movement.
Chen ZM; Cerletti C; de Gaetano G; Bertelé V
Biochem Biophys Res Commun; 1987 Dec; 149(3):1193-9. PubMed ID: 3122746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
